Procyon, operating through its subsidiary AMERX Health Care, develops and sells proprietary wound care and skin care medical products. AMERX's core product line is AMERIGEL, a suite of wound care products built around a proprietary ingredient called Oakin, which AMERX claims promotes wound healing. AMERIGEL products include hydrogel wound dressings, barrier and care lotions, saline wound wash, and post-op surgical kits. Beyond AMERIGEL, AMERX sells collagen-based wound closure products under the HELIX3 and Advantagen brands, a broader line of dressings and wound care kits, and compression therapy garments under the EXTREMIT-EASE brand targeting edema and venous disease. AMERX sells to hospitals, wound care clinics, nursing homes, home health agencies, and individual practitioners, and also sells directly to consumers through retail pharmacies and its own websites. AMERX's primary channel is institutional and retail distributors, supplemented by a growing direct-to-consumer online channel. Medicare reimbursement coding for its products supports institutional adoption. AMERX outsources manufacturing to third-party contract manufacturers and operates with only 20 employees, functioning as a brand- and distribution-focused business rather than a manufacturer.